What is Medication Management?
Medication Management operates as a specialized clinical research organization, focusing on the rigorous assessment of medication safety and efficacy. With a robust presence in Greensboro and Raleigh, the company facilitates critical clinical trials that span complex therapeutic areas, including cardiology and urology. By partnering directly with physician practices, the firm provides a unique value proposition: offering patients access to cutting-edge medical treatments at no cost while simultaneously generating high-fidelity data for the pharmaceutical industry. This dual-focus model not only enhances the standard of care for volunteers but also serves as a vital engine for medical advancement, ensuring that new therapies are vetted through comprehensive, patient-centric assessments.
How much funding has Medication Management raised?
Medication Management has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in Medication Management
PPP
Public-Private Partnership
What's next for Medication Management?
With the recent influx of capital, Medication Management is poised to transition into a more aggressive growth phase, likely focusing on the expansion of its trial site network and the integration of advanced diagnostic technologies. The late-stage nature of this funding suggests a strategic pivot toward operational efficiency and the scaling of its research capacity to meet the increasing demand for decentralized clinical trial services. As the company continues to refine its methodology, it will likely prioritize the diversification of its therapeutic portfolio, potentially entering new medical domains that require specialized patient recruitment and long-term monitoring. This trajectory positions the firm as a critical infrastructure provider in the evolving ecosystem of modern drug development and personalized medicine.
See full Medication Management company page
